PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 272 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $136,598 | -33.9% | 16,359 | +5.2% | 0.00% | 0.0% |
| Q2 2023 | $206,775 | +29.2% | 15,547 | -43.5% | 0.00% | 0.0% |
| Q3 2022 | $160,000 | +32.2% | 27,526 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $121,000 | -39.8% | 27,471 | +24.5% | 0.00% | 0.0% |
| Q1 2022 | $201,000 | -55.4% | 22,061 | 0.0% | 0.00% | -50.0% |
| Q4 2021 | $451,000 | -22.1% | 22,061 | -2.7% | 0.00% | -33.3% |
| Q3 2021 | $579,000 | -27.0% | 22,675 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $793,000 | -12.6% | 22,675 | -16.7% | 0.00% | -25.0% |
| Q1 2021 | $907,000 | -16.9% | 27,235 | -35.3% | 0.00% | -20.0% |
| Q4 2020 | $1,092,000 | -49.1% | 42,110 | -80.6% | 0.01% | -50.0% |
| Q3 2020 | $2,145,000 | +158.1% | 217,280 | -9.8% | 0.01% | +150.0% |
| Q2 2020 | $831,000 | +115.3% | 240,859 | +234.2% | 0.00% | 0.0% |
| Q1 2014 | $386,000 | – | 72,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,660,000 | $24,206,000 | 11.49% |
| Data Collective II GP, LLC | 164,249 | $1,495,000 | 5.44% |
| Decheng Capital Management III (Cayman), LLC | 1,463,872 | $13,321,000 | 4.08% |
| SB Management Ltd | 1,886,107 | $17,164,000 | 3.33% |
| Casdin Capital, LLC | 7,990,652 | $72,715,000 | 3.26% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,225,395 | $11,151,000 | 2.20% |
| Jackson Square Partners, LLC | 22,542,589 | $205,137,000 | 2.04% |
| BOURNE LENT ASSET MANAGEMENT INC | 556,865 | $5,067,000 | 1.59% |
| ARK Investment Management | 27,259,521 | $248,062,000 | 1.04% |
| Nikko Asset Management Americas, Inc. | 14,021,205 | $127,873,000 | 0.94% |